1.13
전일 마감가:
$1.13
열려 있는:
$1.13
하루 거래량:
174.23K
Relative Volume:
0.32
시가총액:
$70.00M
수익:
-
순이익/손실:
$-73.79M
주가수익비율:
-0.6141
EPS:
-1.84
순현금흐름:
$-77.44M
1주 성능:
-5.04%
1개월 성능:
-3.42%
6개월 성능:
-26.14%
1년 성능:
-67.53%
Pyxis Oncology Inc Stock (PYXS) Company Profile
명칭
Pyxis Oncology Inc
전화
(617) 221-9059
주소
321 HARRISON AVENUE, BOSTON
PYXS을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
PYXS
Pyxis Oncology Inc
|
1.13 | 73.72M | 0 | -73.79M | -77.44M | -1.84 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Pyxis Oncology Inc Stock (PYXS) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-11-21 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
2024-11-08 | 개시 | Stephens | Overweight |
2024-08-08 | 개시 | Stifel | Buy |
2024-05-07 | 재개 | Jefferies | Buy |
2024-02-09 | 개시 | BTIG Research | Buy |
2024-01-23 | 개시 | Leerink Partners | Outperform |
2023-09-05 | 개시 | RBC Capital Mkts | Outperform |
2021-11-02 | 개시 | BofA Securities | Neutral |
2021-11-02 | 개시 | Credit Suisse | Outperform |
2021-11-02 | 개시 | Jefferies | Buy |
모두보기
Pyxis Oncology Inc 주식(PYXS)의 최신 뉴스
What drives Pyxis Oncology Inc. stock priceFree Stock Movement Tracking - Autocar Professional
What analysts say about Pyxis Oncology Inc. stockPowerful market insights - jammulinksnews.com
Is Pyxis Oncology Inc. a good long term investmentSuperior risk-adjusted returns - Autocar Professional
Pyxis Oncology Inc. Stock Analysis and ForecastExplosive market performance - jammulinksnews.com
Financial Review: Ainos (NASDAQ:AIMD) vs. Pyxis Oncology (NASDAQ:PYXS) - Defense World
what makes pyxis oncology inc. stock price move sharplyGrowth Optimized Stock Radar - Newser
Why Pyxis Oncology Inc. stock attracts strong analyst attentionFree Low-Risk Investment Plans - Newser
How Pyxis Oncology Inc. stock performs during market volatilityDaily Trade Opportunity - Newser
What makes Pyxis Oncology Inc. stock price move sharplyFree Access to Stock Community - Newser
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives $9.00 Average Price Target from Analysts - Defense World
Pyxis Oncology (NASDAQ:PYXS) Stock Price Up 3.6% – Time to Buy? - Defense World
Pyxis Oncology Appoints New Principal Financial Officer - The Globe and Mail
Pyxis Oncology announces retirement of CFO and COO Pamela Connealy By Investing.com - Investing.com South Africa
Pyxis Oncology, Inc. Announces CFO Changes, Effective July 1, 2025 - MarketScreener
Pyxis Oncology announces retirement of CFO and COO Pamela Connealy - Investing.com
Pyxis Oncology's Equity Incentives: A Strategic Gambit for Clinical Success? - AInvest
Pyxis Oncology, Inc.(NasdaqGS: PYXS) dropped from Russell 3000 Index - MarketScreener
Pyxis Oncology, Inc.(NasdaqGS: PYXS) dropped from Russell 2000 Index - MarketScreener
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
Pyxis Oncology Inc (PYXS) Stock: Navigating a Year of Stock Volatility - investchronicle.com
Pyxis Oncology shareholders elect three directors at annual meeting - Investing.com
Pyxis Oncology Elects New Directors at Annual Meeting - TipRanks
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Ameriprise Financial Inc. Takes $35,000 Position in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Jane Street Group LLC Grows Stake in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Nuveen Asset Management LLC Cuts Stake in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Pyxis Oncology, Inc. (NASDAQ:PYXS) Shares Sold by Deutsche Bank AG - Defense World
ProShare Advisors LLC Makes New Investment in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Northern Trust Corp Sells 15,449 Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Pyxis Oncology Reports Increased Losses Amidst Ongoing R&D Investments - TipRanks
Millennium Management LLC Has $4.65 Million Stock Holdings in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Pyxis Oncology Inc (PYXS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):